Annotated Medicine and Device Lists


Magnesium sulfate

This medicine is present in:

List Section Observation
Bolivia LINAME 2011 - 2013 No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS Others observations:
For use in eclampsia and severe pre-eclampsia and not for other convulsant disorders.
PAHO Strategic Fund Medicine List 12. Anticonvulsant and antiepileptic No observations
Training CSamouge 2022 5. ANTICONVULSANTS/ ANTIEPILEPTICS Others observations:
For use in eclampsia and severe pre-eclampsia and not for other convulsant disorders

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS Others observations:
For use in eclampsia and severe pre-eclampsia and not for other convulsant disorders.
PAHO Strategic Fund Medicine List 12. Anticonvulsant and antiepileptic No observations
Peru 05. Anticonvulsants/Antiepileptics No observations
Training CSamouge 2022 5. ANTICONVULSANTS/ ANTIEPILEPTICS Others observations:
For use in eclampsia and severe pre-eclampsia and not for other convulsant disorders

This medicine is present in:

List Section Observation
Bolivia LINAME 2011 - 2013 No observations
Cuba 05. ANTICONVULSIVOS No observations
Cuba 12.2 Antiarrítmicos No observations
Cuba 26.2 Soluciones parenterales No observations

This medicine is present in:

List Section Observation
Peru 05. Anticonvulsants/Antiepileptics No observations

This medicine is present in:

List Section Observation
Chile Essential and Prioritized Medications No observations

This medicine is present in:

List Section Observation
Colombia 6.4 Liquids and Electrolytes No observations

This medicine is present in:

List Section Observation
Chile Essential and Prioritized Medications No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations

Information Resources: Magnesium sulfate

Loading ...
Loading ...
Loading ...
No information available